1. ANDERSON R.A., WU F.C.W.: Comparison between testosterone enanthate — induced azoospermia and oligozoospermia in a male contraceptive study — II Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone enanthate. J. Clin. Endocrinol. Metab., 1996, 81: 896–901.
2. BEBB R.A., ANAWALT B.D., CHRISTENSEN B., PAULSEN C.A., BRENNER W.J., MATSUMOTO A.M.: Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraception approach. J. Clin. Endocrinol. Metab., 1996, 81: 757–762.
3. BEHRE H.M., NASHAN D., HUBERT W., NIESCHLAG E.: Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception. J. Clin. Endocrinol. Metab., 1992, 74: 84–90.
4. BREMNER W.J., BAGATELL C.J., STEINER R.A.: Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive. J. Clin. Endocrinol. Metab., 1991, 73: 465–469.
5. GUERIN J.F., ROLLET J.: Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens. Int. J. Androl., 1988, 11: 187–199.